Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mouli Pal"'
Autor:
Yunfeng Liu, Shan Su, Sarah Shayo, Weili Bao, Mouli Pal, Kai Dou, Patricia A. Shi, Banu Aygun, Sally Campbell-Lee, Cheryl A. Lobo, Avital Mendelson, Xiuli An, Deepa Manwani, Hui Zhong, Karina Yazdanbakhsh
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 18 (2023)
Sickle cell disease (SCD) is a hereditary hemoglobinopathy characterized by painful vaso-occlusive crises (VOC) and chronic hemolysis. The mononuclear phagocyte system is pivotal to SCD pathophysiology, but the mechanisms governing monocyte/macrophag
Externí odkaz:
https://doaj.org/article/93a992862e794a0f98877ac118afd2c6
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/ad1ee0823dd34c2ba2c67cb2730c7d2c
Autor:
Caterina P. Minniti, Deepa Manwani, Weili Bao, Xiuli An, Yunfeng Liu, Cheryl A. Lobo, Rikang Wang, Mouli Pal, Karina Yazdanbakhsh, Hui Zhong, William B. Mitchell, Patricia A. Shi
Publikováno v:
Blood. 137:269-280
Red blood cell alloimmunization remains a barrier for safe and effective transfusions in sickle cell disease (SCD), but the associated risk factors remain largely unknown. Intravascular hemolysis, a hallmark of SCD, results in the release of heme wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c66973958bca7c2f73c26ff10bef5005
https://doi.org/10.1182/blood.2020008511
https://doi.org/10.1182/blood.2020008511
Autor:
Yunfeng Liu, Weili Bao, Hui Zhong, Xiuli An, Karina Yazdanbakhsh, Cheryl A. Lobo, Mouli Pal, Deepa Manwani, Patricia A. Shi
Publikováno v:
Blood
Patients with sickle cell disease (SCD) suffer from intravascular hemolysis-associated vascular injury and tissue damage. Classical monocytes (CMo), which are the most abundant of circulating monocytes, are activated in SCD, but the cause and consequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dabd40eb65da9f1d5053b1a37f353cea
https://europepmc.org/articles/PMC8570059/
https://europepmc.org/articles/PMC8570059/
Autor:
Marilis Rodriguez, Chengjie Gao, Huan Zhang, Karina Yazdanbakhsh, Parakkal Jovvian George, Christopher D. Hillyer, Shabnam Jawahar, Fabian Schmidt, Weili Bao, Frauke Muecksch, Brett P. Ransegnola, Yiska Weisblum, Emily Schnall, Paul D. Bieniasz, Nancy Tricoche, Daniel K. Jin, Theodora Hatziioannou, Larry L. Luchsinger, Donna Strauss, Mouli Pal
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 1
Journal of Clinical Microbiology
article-version (status) pre
article-version (number) 1
Journal of Clinical Microbiology
The development of neutralizing antibodies (NAbs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following infection or vaccination is likely to be critical for the development of sufficient population immunity to drive cessatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9197def1b9c007bb3bf523c8bc9e926f
https://doi.org/10.1128/jcm.02005-20
https://doi.org/10.1128/jcm.02005-20